Omnicell (OMCL) EBIT (2010 - 2026)

Omnicell (OMCL) has reported EBIT for 17 consecutive years, with $32.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT rose 299.62% year-over-year to $32.4 million in Q2 2026; TTM through Jun 2026 was $58.0 million, a 274.89% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, up 1431.16% from the prior year.
• EBIT was $32.4 million for Q2 2026 at Omnicell, up from $16.9 million in the prior quarter.
• Over five years, EBIT peaked at $32.4 million in Q2 2026 and troughed at -$38.4 million in Q4 2022.
• A 5-year average of $978277.8 and a median of $5.8 million in 2022 frame the typical range for EBIT.
• Across the five-year window, EBIT plunged 551.67% in 2023 and soared 299.62% in 2026, its largest moves.
• Over 5 years, EBIT stood at -$38.4 million in 2022, then jumped by 39.09% to -$23.4 million in 2023, then surged by 153.05% to $12.4 million in 2024, then sank by 96.65% to $415000.0 in 2025, then soared by 7719.04% to $32.4 million in 2026.
• The last three EBIT figures came in at $32.4 million (Q2 2026), $16.9 million (Q1 2026), and $415000.0 (Q4 2025), per Business Quant data.